Eisai Pharmaceuticals India Pvt. Ltd clinical trials

A country office of Eisai Co., Ltd.

The registry lists 3 studies whose lead sponsor is Eisai Pharmaceuticals India Pvt. Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 6, 2026.

Status

Completed: 3

Phase

Phase 4: 2

Where

India: 3

Registry sponsor names on this page

Eisai Pharmaceuticals India Pvt. Ltd3 studies

Something wrong with this grouping? Tell us on the Eisai Co., Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Eisai Co., Ltd. studies →

A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid CancerCompletedNCT03573960Phase 4
Sponsor listed in the registry: Eisai Pharmaceuticals India Pvt. Ltd
A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCCCompletedNCT04297254Phase 4
Sponsor listed in the registry: Eisai Pharmaceuticals India Pvt. Ltd
A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or OlderCompletedNCT03836924
Sponsor listed in the registry: Eisai Pharmaceuticals India Pvt. Ltd